Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the safety, efficacy, hemodynamic and respiratory stability of a low-dose of dexmedetomidine infusion in post-operative surgical in-patients undergoing thoracic surgery after discharge from PACU or ICU.

Clinical Trial Description

Dexmedetomidine has sedative and analgesic properties that may reduce the opioid requirement in post-operative patients, thereby decreasing the chance of post-operative respiratory depression that occurs with opioid administration. In addition, patients may be more alert with less opioid medication. Currently, dexmedetomidine is not approved for use longer than twenty-four hours and must only be administered in the Intensive Care Unit where patients can be continuously monitored.

This is a prospective, double-blinded, control group pilot study. One group (the control group) will receive a normal saline infusion and the second group (the treatment group) will receive low-dose Dexmedetomidine for up to 24 hours after they are admitted to an open nursing unit (not an Intensive Care Unit).

During the surgery, the anesthesiologist will administer dexmedetomidine during the surgical procedure after an optional loading dose. All patients will receive pain medication using a Patient Controlled Analgesia (PCA) pump as per standard practice. In addition, if the physician deems necessary, an On-Q Pain Pump will deliver local anesthetic surrounding the incision under direction of the surgeon.

Before discharge from the PACU or ICU, each subject will receive either low-dose dexmedetomidine or normal saline using a continuous infusion pump for up to 24 hours after the subject is discharged from either the PACU or the ICU to an open nursing unit. While on the open nursing unit patient vital signs, oxygen saturation, Ramsay score and pain score will recorded every two hours until the treatment drug is stopped. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00345384
Study type	Interventional
Source	Baylor Research Institute
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	May 2008
Completion date	January 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02489526` - Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Colorectal Surgery	Phase 2
Terminated	`NCT05146453` - Sternotomies and PectoIntercostal Fascia Blocks in Fast-Track Cardiac Anesthesiology	Phase 4
Completed	`NCT05635916` - Trial of Liposomal Bupivacaine for TKA	Phase 4
Recruiting	`NCT06028126` - Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial	N/A
Not yet recruiting	`NCT03591172` - Using Three Different Final Irrigants and Showing Their Effects on the Success of Revascularization	N/A
Completed	`NCT01686802` - Post-operative Oral Morphine Versus Ibuprofen	Phase 2
Completed	`NCT01667445` - Evaluation of the Use of Spinal Epimorph in Total Knee Arthroplasty	Phase 4
Completed	`NCT01444924` - Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery	Phase 2
Completed	`NCT00830089` - Trial of a Transversus Abdominis Plane (TAP) Block in Laparoscopic Colorectal Surgery	N/A
Completed	`NCT00968955` - Effect of Local Infiltration Analgesia in Total Hip Arthroplasty	Phase 4
Completed	`NCT00847093` - LMX-4 for Postoperative Pain Management in Infants and Children Undergoing Penoplasty Surgery	Phase 4
Terminated	`NCT00875862` - Shoulder Adhesive Capsulitis and Ambulatory Continuous Interscalene Nerve Blocks	Phase 4
Completed	`NCT00390312` - Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction	Phase 2
Recruiting	`NCT05278494` - Dextromethorphan for Treatment of Postoperative Pain	N/A
Recruiting	`NCT05973045` - Investigation of the Effect of Distention Medium Temperature on Image Quality, Hyponatremia Risk, and Post-operative Pain in Operative Hysteroscopy	N/A
Not yet recruiting	`NCT04999670` - Fascial Closure and Post-caesarean Pain	N/A
Enrolling by invitation	`NCT04346407` - Dronabinol for Post-operative Pain After Lumbar Fusion	Phase 4
Completed	`NCT03635515` - Occurrence of Post-op Pain Following Gentlewave	N/A
Terminated	`NCT03201809` - Comparison of Preoperative Ultrasound Guided Pectoralis Nerve Block Placement Versus Intra-operative Placement: A Prospective Randomized Trial	N/A
Completed	`NCT03254056` - Fascial Closure Techniques Post-Operative Pain Laparoscopy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms